Company / Shareholders' Equity
ANAPTYSBIO, INC Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$37.2M
FY2025
5-year range
$37.2M / $405.0M
FY2021-FY2025
Trend
-47.5%
vs FY2024
Sector context
#185 of 213
Health Care
What the data says
ANAPTYSBIO, INC's shareholders' equity of $37M is lower than 87% of companies in the Health Care sector (FY2025). Shareholders' Equity has declined for 5 consecutive years, from $486M in FY2020 to $37M in FY2025.
Based on SEC 10-K filings.
$37M in FY2025 with a 5-year CAGR of -40.2%.
Declined from $88M to $37M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -54.6%
- 5-Year CAGR
- -40.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 213This company $37.2M Sector average $2.5B
▼
-98.5% below sector average
Key checks
Key Insights
- ANAPTYSBIO, INC's shareholders' equity has declined for 5 consecutive years.
- 5-year CAGR of -40.2%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 47.5% year-over-year.
- Ranks #185 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $37.2M | -47.5% |
| FY2024 | $70.9M | -19.6% |
| FY2023 | $88.1M | -77.8% |
| FY2022 | $396.7M | -2.0% |
| FY2021 | $405.0M | -16.7% |
| FY2020 | $486.4M | +58.1% |
| FY2019 | $307.6M | -36.8% |
| FY2018 | $486.4M | +1482.5% |
| FY2017 | -$35.2M | +8.0% |
| FY2016 | -$38.2M | -8.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026